Available Equipment
  • Volumetric micro-computed tomography (GE Locus Ultra microCT)
  • High resolution specimen micro-computed tomography (Siemens Inveon microCT)
  • 7T magnetic resonance imaging and spectroscopy (Bruker 30 cm 7T MRI)
  • 1T magnetic resonance imaging (Aspect Imaging)
  • Micro-positron emission tomography (Siemens Focus 220 PET)
  • Single photon emission computed tomography with CT (Bioscan nanoSPECT/CT)
  • Image-guided radiation treatment unit (Precision X-RAY XRAD 225Cx micro-IGRT) with conebeam CT and a bioluminescence camera
  • Optical imaging: bioluminescence and fluorescence (Xenogen IVIS Imaging System 100,VisEn FMT2500, CRi Maestro, Leica FCM1000 Fluorescent Con-Focal Microscope, LCD tunable filter camera) and biopsy guidance (NDI Polaris Optical Tracking)
  • Small animal ultrasound (VisualSonics Vevo 2100 system) with photoacoustic capabilities (VisualSonics LAZR system)
Unique Capacities
  • Equipped to support small animal imaging studies
  • Multimodality imaging with co-registration and analysis
  • Option of using multimodal contrast agents/probes (optical/CT/MRI/PET)
  • Availability of a variety of radionuclides and radiopharmaceuticals
  • New magnetic resonance imaging technologies for thermometry, cell tracking, contrast agent development and surgical intervention
  • Planar (hyperspectral) and 3D volumetric optical fluorescence tomographic imaging using novel optical fluorescence agents
  • Quantitative 3D fluorescence imaging of murine models (VisEn FMT system)
Using the Facility
  • Open to academic and external users
  • Training and technical support is available
Usage Arrangements
Collaborative and/or user fees; please contact STTARR for cost estimates for budgetary purposes and to inquire about our competitive price structure.
Contacts

Dr. Justin Grant                                                  
STTARR Research Program Manager            

Deborah Scollard
Core II Manager

Princess Margaret Cancer Research Tower
7th Floor, 101 College Street
Toronto, Ontario, M5G 1L7

The preclinical core of STTARR is designed to advance the development and rapid translation of novel biologic imaging and targeted radiation treatment strategies in various animal models. The facility is led by Scientific Director Dr. David Jaffray.